<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"CVD":1,
"Prohibitin":1,
"mitochondria":2,
"other diseases":1,
"oxidative stress":1,
"post-transcriptional and post-translational regulation":1,
"Larynx":2,
"Magnetic resonance imaging":1,
"Neoplasm":1,
"Staging":1,
"Surface coil":1,
"Adjuvant radiotherapy":1,
"Breast cancer":6,
"Breast irradiation":1,
"Dosimetry":1,
"Organs at risk":1,
"Prone crawl position":1,
"Prone position":1,
"Regional nodal irradiation":1,
"VMAT":1,
"CTHRC1":1,
"Metastasis":4,
"Prognosis":8,
"miR-30c":1,
"BED":1,
"Biologically effective dose":1,
"Head and neck radiation":1,
"Hypothyroidism":4,
"Late toxicity":1,
"British Thyroid Association 2014 guidelines":1,
"Differentiated thyroid cancer":5,
"E2F1":1,
"HBXIP":1,
"PKM2":1,
"proliferation":3,
"adrenal cortex":1,
"molecular genetics":1,
"neoplasia":1,
"neuroendocrine tumors":2,
"thyroid":12,
"BRAF mutation":1,
"DNA methylation":1,
"Personalized therapy":1,
"Thyroid cancer":37,
"Neck approach":1,
"Sternotomy":1,
"Substernal goiter":1,
"Tertiary center":1,
"Thyroidectomy":9,
"Breast tumor":1,
"Giant cell tumor":1,
"Giant cell tumor of soft tissue in breast":1,
"Extrathyroidal extension":2,
"Lateral lymph node metastasis":1,
"Papillary thyroid microcarcinoma":4,
"Predictive factor":1,
"4K 3D video microscope":1,
"Pituicytoma":1,
"Preoperative embolization":1,
"Spindle cell oncocytoma":1,
"fine-needle aspiration cytology":1,
"histology":1,
"thyroid neoplasms":9,
"ultrasonography":5,
"Central neck dissection":2,
"Lymph node metastasis":3,
"Lymph node ratio":1,
"Papillary thyroid carcinoma":16,
"JAK/STAT signaling pathway":1,
"JAK1":1,
"epithelial-mesenchymal transition":1,
"invasion":1,
"microRNA-520a-3p":1,
"migration":2,
"TRAF6":1,
"inflammation":3,
"miR-146b-5p":1,
"microRNA":1,
"renal cell carcinoma (RCC)":1,
"Epidemiology":2,
"Second primary thyroid cancer":1,
"Surveillance":1,
"and End Results":1,
"head and neck cancer":4,
"radiation":1,
"radiation-related malignancies":1,
"second primary malignancies":1,
"IDH2":1,
"Oncomine":1,
"PIK3CA":1,
"breast":1,
"carcinoma":2,
"papillary":2,
"tall cell":1,
"antidiabetic drug":1,
"cancer":7,
"dipeptidyl peptidase-4 inhibitor":1,
"type 2 diabetes":1,
"CUSUM":1,
"Endoscopic thyroid surgery":1,
"Learning curve":1,
"chemotherapy":1,
"maxillary sinus cancer":1,
"survival outcomes":1,
"central nervous system (CNS) tumor":1,
"late effects":1,
"radiation therapy":1,
"sarcoma":1,
"Cervical chyle fistula":1,
"Cirugía":1,
"Fístula quilosa cervical":1,
"Medium-chain fatty acids":1,
"Octreotida":1,
"Octreotide":2,
"Surgery":2,
"Tiroidectomía":1,
"Ácidos grasos de cadena media":1,
"HOXD cluster antisense RNA 1":1,
"biomarker":5,
"long noncoding RNA":1,
"3D quantitative nuclear telomere analysis":1,
"cancer stem-like cells":1,
"quantitative fluorescence in situ hybridization":1,
"BRAF":1,
"Central lymph node metastases":1,
"cN0":1,
"mPTC":1,
"Artificial intelligence":1,
"Fine-needle aspiration":5,
"Thyroid nodule":9,
"Epstein-Barr virus":1,
"anoikis":1,
"tumor development":1,
"MEN2":2,
"Medullary thyroid carcinoma":5,
"Prophylactic":1,
"Stat3":2,
"hnRNP-A1":1,
"let-7a-5p":1,
"pyruvate kinase isoenzyme type M2":1,
"SLUG":1,
"SNAIL":1,
"TWIST":1,
"E-CAD":1,
"follicular thyroid tumour":1,
"anaplastic thyroid carcinoma":2,
"fine needle aspiration":3,
"mediastinal seminoma":1,
"GLP-1 receptor agonist":1,
"exenatide":1,
"pancreatic cancer":1,
"molecular testing":1,
"laparoscopic gastrectomy":1,
"liver retraction":1,
"needle forceps":1,
"silicone disc":1,
"Contralateral lesions":1,
"Encapsulated tumors":1,
"FVPTC":1,
"Multifocality":2,
"NIFTP":1,
"Pathology":1,
"CyclinD1":1,
"Hurthle cell tumors":1,
"Immunohistochemistry":2,
"Ki-67":1,
"P53":1,
"Bioinformatics analysis":1,
"Long non-coding RNA":1,
"MIR22HG":1,
"NGS":1,
"cytology slide":1,
"microRNA classifier":1,
"personalized medicine":1,
"thyroid cancer diagnostic test":1,
"differentiated thyroid carcinoma":3,
"quality of care":1,
"thryoidectomy":1,
"thyroid nodules":5,
"CT":1,
"diagnosis":4,
"differential":1,
"dual-energy":1,
"iodine/analysis":1,
"microRNA classification":1,
"mutation analysis":1,
"risk reclassification":1,
"Chest–breast approach":1,
"Clearance of lateral lymph nodes":1,
"Endoscopic thyroidectomy":1,
"Lateral neck dissection":1,
"endobronchial tumor":1,
"granular cell tumor":1,
"Completion thyroidectomy":1,
"Complications":1,
"Hemithyroidectomy":2,
"Hormone replacement":1,
"Isthmolobectomie":1,
"Supplémentation hormonale":1,
"Thyroïdectomie totale":1,
"Total thyroidectomy":5,
"Totalisation":1,
"messenger RNA":1,
"Follicular lesions":1,
"Medical errors":1,
"Minimally invasive follicular thyroid carcinoma":1,
"Tissue sampling":1,
"SNHG15":1,
"lncRNA":1,
"melatonergic system":1,
"molecular marker":1,
"mutational burden":1,
"neoantigen abundance":1,
"pan-cancer analyses":1,
"tumor microenvironment":1,
"Cardiotoxicity":1,
"Checkpoint inhibitor toxicity":1,
"Hepatotoxicity":1,
"Immunotherapy":2,
"Metastatic giant cell bone tumor":1,
"Thyroid toxicity":1,
"Endocrine surgical procedures":1,
"Hypocalcaemia":1,
"Thyroid diseases":1,
"DNA mutational analysis":1,
"High-throughput nucleotide sequencing":1,
"Translational research":1,
"African American":1,
"germline variants":1,
"radioiodine refractory":1,
"2015 American Thyroid Association management guideline":1,
"Thyroid Imaging Reporting and Data System":1,
"Ultrasound":9,
"Adrenal tumor":1,
"Cortisol":1,
"Cushing’s syndrome":1,
"Cyclic-AMP":1,
"GNAS":1,
"Protein kinase A":1,
"ARMS":1,
"BRAF V600E mutation":1,
"Droplet digital PCR":1,
"Survivin":1,
"Diagnostic marker":1,
"PTC":5,
"Plasma microRNA":1,
"qRT-PCR":1,
"Cancer papillaire de la thyroïde":1,
"Differential expression":1,
"Expression différentielle":1,
"MicroARNs":1,
"MicroRNAs":1,
"Encapsulated follicular variant":1,
"Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)":1,
"Oncocytic":2,
"RAS":1,
"Cancer stem cells":2,
"Gene expression":2,
"Tumorigenesis":1,
"Apoptosis":3,
"LncRNA ANRIL":1,
"Papillary thyroid cancer":4,
"Propofol":1,
"convolutional neural network (CNN)":1,
"deep learning":3,
"Cancer stem cell":1,
"Gallbladder carcinoma":1,
"Lnc-DILC":1,
"β-Catenin":1,
"2-Deoxy-2-[18F]fluoro-D-glucose ([18F]FDG)":1,
"Glucose-6-phosphatase (G6Pase)":1,
"Positron emission tomography (PET)":1,
"Endoscopic transsphenoidal surgery":1,
"Hyponatremia":1,
"Pituitary adenoma":2,
"IgG4-related disease":1,
"Parathyroid adenoma":2,
"Parathyroid adenoma with prominent lymphocytic infiltrate":1,
"Parathyroid neoplasms":1,
"Angiogenesis":2,
"Cardio-oncology":1,
"Hypertension":2,
"Renal cell carcinoma":3,
"TCGA":1,
"network-regularized high dimensional cox regression":1,
"pathway databases":1,
"Fatty liver":1,
"HCC":1,
"NASH":1,
"Physiopathology":1,
"SP1":1,
"c-Myb":1,
"miR-1258":1,
"oral squamous cell carcinoma":1,
"false negative rate":1,
"Discharge":1,
"follow-up":1,
"recurrence":2,
"thyroid carcinoma":4,
"Acromegaly":3,
"Somatostatin analog treatment":1,
"Thyroid nodule volume":1,
"DNA mismatch repair":1,
"Lynch syndrome":1,
"follicular thyroid cancer":1,
"microsatellite instability":1,
"FMO1":1,
"RFS":1,
"classical papillary thyroid cancer":1,
"Anaplastic thyroid cancer":2,
"PD-1":1,
"PD-L1":1,
"BRAF V600E":1,
"Warburg effect":1,
"metabolic reprogramming":1,
"mitochondrial biogenesis":1,
"indeterminate":1,
"malignancy":2,
"pediatric":1,
"treatment":1,
"Microwave":1,
"Papillary carcinoma":2,
"Thermal ablation":1,
"multifocal":1,
"digital pathology":1,
"noninvasive follicular thyroid neoplasm with papillary-like nuclear features":1,
"nuclear scoring system":1,
"observer variation":1,
"tumors of uncertain malignant potential":1,
"ThyroSeq":1,
"benign call rate":1,
"indeterminate FNA":1,
"next generation sequencing":1,
"BRAFV600E":1,
"Artificial intelligence (AI)":2,
"Post-mortem computed tomography (CT)":1,
"Thyroid cartilage":1,
"Lenvatinib":1,
"Sorafenib":2,
"Thyroid cancer treatment":1,
"Treatment duration":1,
"Cancer progression":1,
"Moonlighting functions":1,
"Non-canonical localization":1,
"Nuclear translocation":1,
"Pyruvate kinase M2":1,
"BRCA1":1,
"correlation":1,
"ethnicity":1,
"meta-analysis":3,
"polymorphisms":1,
"Modena retractor":1,
"robotic":1,
"transaxillary":1,
"ATM":1,
"autophagy":2,
"lipophagy":1,
"mitophagy":1,
"pexophagy":1,
"selective autophagy":1,
"Hürthle cell":1,
"loss of heterozygosity":1,
"mtDNA":1,
"AIP":1,
"FIPA":1,
"lanreotide":1,
"pasireotide":1,
"resistant":1,
"somatostatin analog":1,
"Endoscopic thyroidectomy using vestibular approach":1,
"scar free thyroidectomy":1,
"transoral endoscopic thyroidectomy":1,
"Helical CT":1,
"Imaging, diagnostic":1,
"Neck":2,
"Parathyroid cancer":1,
"F-choline":1,
"PET/CT":3,
"elderly":1,
"high-risk patients":1,
"cardiovascular morbidity":1,
"cerebrovascular morbidity":1,
"hyperlipidemia":1,
"navitoclax":1,
"proto-oncogene proteins B-raf":1,
"vemurafenib":1,
"Blood supply protection":1,
"Level VI dissection":1,
"Superior parathyroid":1,
"Key gene":1,
"Papillary thyroid carcinom":1,
"Signaling pathway":1,
"Survival analysis":1,
"18F-Choline":1,
"18F-FDG":2,
"18F-FDOPA":1,
"Gallium-68":1,
"Primary hyperparathyroidism":1,
"Somatostatin":1,
"The Cancer Genome Atlas":1,
"microRNA-122":1,
"overall survival rate":1,
"Computed Tomography (CT)":1,
"Magnetic resonance imaging (MRI)":1,
"Ethanol ablation":1,
"Guidelines":1,
"Minimally invasive therapy":1,
"Thyroid neoplasm":2,
"FNA":1,
"miR-137":1,
"miR-181b":1,
"miR-214":1,
"miR-222":1,
"adjuvant therapy":1,
"consensus":1,
"radioiodine-refractory thyroid cancer":1,
"remnant ablation":1,
"ultra-low-dose CT":1,
"Carcinoma de células renales":1,
"Neoplasia metastásica":1,
"Neoplasm metástasis":1,
"Tiroides":1,
"DANCR":1,
"large intervening non-coding RNA":1,
"Epidemiology and prevention":1,
"Italy":1,
"incidence":2,
"mortality":1,
"time trend":1,
"Negative conversion":1,
"Radioactive iodine ablation":2,
"Thyroglobulin antibody":1,
"Thyroid peroxidase antibody":1,
"Area under the curve":1,
"Machine learning":2,
"Biopsy, needle":1,
"Mutation":2,
"acute myeloid leukemia":1,
"DALY":1,
"Ecuador":1,
"Latin America":1,
"YYL":1,
"Papillary thyroid cancer ∙ LncRNA ∙ proliferation ∙ biomarker ∙ MAPK":1,
"Diagnostic accuracy":1,
"Microcalcifications":1,
"Sri Lanka":1,
"Thyroid malignancy":1,
"Ultrasound characteristics":1,
"dedifferentiated":1,
"endocrine system":1,
"thyroid disease":2,
"Calcium":1,
"Hypocalcemia":1,
"Hypoparathyroidism":1,
"Echogenic foci":1,
"Thyroid TIRADS":1,
"cancer screenig":1,
"health behavior":1,
"Cancer survivorship":1,
"Neurocognitive function":1,
"Systematic review":1,
"HPV":1,
"aspiration cytopathology":1,
"bone and soft tissue cytology":1,
"endocrine glands":1,
"head and neck cytology":1,
"immunochemistry":1,
"immunocytochemistry":1,
"molecular diagnostics":1,
"neuroendocrine and endocrine lesions":1,
"non-gynecologic cytopathology":1,
"thyroid cytology":1,
"Algorithm":1,
"Genomic":1,
"Hürthle":1,
"Personalized healthcare":1,
"RNA-seq":1,
"Benign thyroid nodule":1,
"fine needle aspiration cytology":1,
"Lutetium":1,
"Peptide receptor radionuclide therapy":1,
"Receptors, somatostatin":1,
"Thyroid cancer, medullary":1,
"Carcinoma, papillary":2,
"CYFRA 21 1":1,
"biomarkers":1,
"lymph nodes":1,
"apparent diffusion coefficient":1,
"diffusion-weighted imaging":1,
"chest-breast approach":1,
"endoscopy":1,
"lateral lymph nodes":1,
"lymph node dissection":2,
"clinical pathology":1,
"9/11 disaster":1,
"World Trade Center":1,
"surveillance bias":1,
"Follicular neoplasm":1,
"TROP-2":1,
"Incidental papillary thyroid microcarcinoma":1,
"Benign breast lesion":1,
"Efficiency":1,
"Microwave ablation":1,
"Safety":1,
"circulating tumor DNA":1,
"liquid biopsy":1,
"target region sequencing":1,
"alternative splicing events":1,
"precision medicine":1,
"prognostic signature":1,
"splicing factors":1,
"Carcinoma, Medullary":1,
"HPV-related oropharyngeal cancer":1,
"Squamous cell carcinoma":3,
"TNM staging":1,
"Distant metastasis":1,
"Renal tumor":1,
"Hypothyroïdie":1,
"Nivolumab":1,
"Thyroiditis":1,
"Thyrotoxicose":1,
"Thyrotoxicosis":2,
"Thyroïdite":1,
"ASD":1,
"Autism":1,
"Comorbidity":1,
"Multimorbidity":1,
"Transcriptome":1,
"daily walking duration":1,
"physical activity":1,
"prevention":1,
"Aspirin":1,
"Metformin":1,
"endocrine cancer":1,
"plastic and reconstructive surgery":1,
"radiology":1,
"skin cancer":1,
"medullary thyroid cancer":2,
"small cell carcinoma":1,
"telomerase reverse transcriptase":1,
"v-raf murine sarcoma viral oncogene homologue B1":1,
"ATP2A3":1,
"Ca2+ release":1,
"ER stress":1,
"Salinomycin":1,
"FOXD2-AS1":1,
"TERT":1,
"18FDG-PET":1,
"Hashimoto's disease":1,
"autoimmune thyroid disease":1,
"chromogranin A":1,
"metanephrines":1,
"paraganglioma":1,
"pheochromocytoma":2,
"ATC":1,
"FTC":1,
"HSPA9":1,
"MTC":1,
"Mito-CP":1,
"mortalin":1,
"ALK-positive adenosquamous carcinoma":1,
"ALK-positive lung cancer":1,
"Alectinib":1,
"Interrater reliability":1,
"agreement":1,
"TIRADS":1,
"Clear cell carcinoma":1,
"Metastatic renal cell cancer":1,
"Sunitinib":1,
"TSH":1,
"Thyroid-stimulating hormone":1,
"Functioning metastases":1,
"papillary carcinoma thyroid":1,
"Hypercalcemia":1,
"hyperparathyroidism":2,
"minimally invasive surgical procedures":1,
"reoperation":1,
"single-photon emission computed tomography/computed tomography":1,
"low-risk differentiated thyroid carcinoma":1,
"stimulated thyroglobulin":1,
"pathergy":1,
"pyoderma gangrenosum":1,
"multiple endocrine neoplasia type 2A":1,
"rearranged during transfection proto-oncogene":1,
"Follicular proliferation":1,
"Lobectomy":1,
"TIR3B":1,
"Fine needle aspiration citology":1,
"Follicular":1,
"Goiter":1,
"Kidney transplantation":1,
"Skip metastasis":1,
"Da Vinci Xi":1,
"Remote access surgery":1,
"Robotic-assisted":1,
"Trans-axillary approach":1,
"American Thyroid Association guidelines task force":1,
"Lobohystmectomy":1,
"Thyroid surgery":1,
"Elderly patients":1,
"Prophylactic central neck dissection":1,
"Hypocalcemia,Thyroidectomy,Thyroid disease,parathyroid":1,
"Ossification, Heterotopic":1,
"Thyroid Gland":2,
"EMT":1,
"EYA1":1,
"FNDC3B":1,
"hepatocellular carcinoma":2,
"tumor growth":1,
"ectopic thymus":1,
"elastography":1,
"metastatic lymph node":1,
"AKT":1,
"NECTIN4":1,
"colorectal cancer":2,
"extranodal extension":1,
"neutrophil to lymphocyte ratio":1,
"nomograms":1,
"oral cancer":1,
"perineural spread":1,
"YAP":1,
"cancer metabolism":1,
"glucose transporter":1,
"quality of life":1,
"NUPR1":1,
"PDGFA":1,
"Thyroid hormone receptor":1,
"Dual energy CT":1,
"TNM":1,
"cervical lymph nodes":1,
"lymphadenopathy":1,
"spectral CT":1,
"thyroid cartilage invasion":1,
"bone methastases":1,
"long bones":1,
"surgical treatment":1,
"Calcitonin":2,
"Nodular disease":1,
"Bone":1,
"Metastases":1,
"Antineoplastic agents":1,
"Treatment outcome":1,
"Tyrosine kinase inhibitors":1,
"Carcinoembryonic antigen":1,
"Cisplatin":1,
"Iodine Contrast Media":1,
"Photoelectric":1,
"Radiotherapy":1,
"dysphagia":1,
"laryngology":1,
"miscellaneous":1,
"neurological disorders":1,
"otolaryngology":1,
"rehabilitation":1,
"swallow/dysphagia":1,
"vocal cord dysfunction":1,
"vocal fold paralysis":1,
"Thyroid cancer cells":1,
"aquaporin-1":1,
"miR-223":1,
"Aging":1,
"CD44":1,
"Splice variant":1,
"management of thyroid nodules":1,
"Computed Tomography":1,
"Hypervascular Mass":1,
"Neoplasm Metastasis":1,
"Positron Emission Tomography Computed Tomography":1,
"Renal Cell":1,
"PCNA":1,
"tumor stage":1,
"lymphovascular invasion":1,
"thyroid micropapillary carcinoma":1,
"thyroid papillary carcinoma":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2019年4月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
